Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


2 Am J Med
1 Biochem Biophys Res Commun
1 BMC Pediatr
1 Drug Saf
2 Epidemiol Infect
2 J Clin Microbiol
1 J Infect Dis
2 J Virol Methods
1 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
1 PLoS Biol
4 PLoS Comput Biol
16 PLoS One
5 Proc Natl Acad Sci U S A
3 Vaccine
3 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Med

  1. ADEPOJU VA, Imoyera W
    Addressing COVID Vaccine Hesitancy and Its Impact on Road Crashes.
    Am J Med. 2023;136:e179.

  2. HUBER JM, Wieland ML, Bornstein SL, Mauck KF, et al
    Update in Outpatient General Internal Medicine: Practice-Changing Evidence Published in 2022.
    Am J Med. 2023;136:869-873.
    PubMed         Abstract available

    Biochem Biophys Res Commun

  3. YAO Y, Zhang Y, Li Z, Chen Z, et al
    A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.
    Biochem Biophys Res Commun. 2023;675:113-121.
    PubMed         Abstract available

    BMC Pediatr

  4. DULUDE C, Sutherland S, Vanderhout S, King WJ, et al
    A pediatric virtual care evaluation framework and its evolution using consensus methods.
    BMC Pediatr. 2023;23:402.
    PubMed         Abstract available


  5. BROWN RL, Benjamin L, Lunn MP, Bharucha T, et al
    Pathophysiology, diagnosis, and management of neuroinflammation in covid-19.
    BMJ. 2023;382:e073923.
    PubMed         Abstract available

    How do UK broadcast media deal with covid misinformation?
    BMJ. 2023;382:1684.

    Drug Saf

  7. WALTON M, Pletzer V, Teunissen T, Lumley T, et al
    Adverse Events Following the BNT162b2 mRNA COVID-19 Vaccine (Pfizer-BioNTech) in Aotearoa New Zealand.
    Drug Saf. 2023;46:867-879.
    PubMed         Abstract available

    Epidemiol Infect

    Mortality associated with Omicron and influenza infections in France before and during the COVID-19 pandemic.
    Epidemiol Infect. 2023 Aug 25:1-22. doi: 10.1017/S0950268823001358.

  9. VERONESE G, Mahamid F, Bdier D
    Concerns, perceived risk, and hesitancy on COVID-19 vaccine: a qualitative exploration among university students living in the West Bank.
    Epidemiol Infect. 2023;151:e139.
    PubMed         Abstract available

    J Clin Microbiol

  10. NARAYANASAMY S, Veldman TH, Lee MJ, Glover WA 2nd, et al
    RADx-UP Testing Core: Access to COVID-19 Diagnostics in Community-Engaged Research with Underserved Populations.
    J Clin Microbiol. 2023;61:e0036723.
    PubMed         Abstract available

  11. BULTERYS PL, Leung NY, Saleem A, Budvytiene I, et al
    Postpandemic Effects of COVID-19 Shelter-in-Place Orders on the Gastrointestinal Pathogen Landscape.
    J Clin Microbiol. 2023;61:e0038523.

    J Infect Dis

  12. SUN X, Belser JA, Pulit-Penaloza JA, Brock N, et al
    Pathogenesis and transmission assessment of three swine-origin influenza A(H3N2) viruses with zoonotic risk to humans isolated in the U.S from 2017-2020.
    J Infect Dis. 2023 Aug 21:jiad359. doi: 10.1093.
    PubMed         Abstract available

    J Virol Methods

  13. DI DYW, Li B, Jeon MK, Yan T, et al
    Comparing solid-based concentration methods for rapid and efficient recovery of SARS-CoV-2 for wastewater surveillance.
    J Virol Methods. 2023;320:114790.
    PubMed         Abstract available

  14. DERIN DC, Gultekin E, Taskin II, Otlu B, et al
    Designing of rapid assay for the detection of RdRp/Orf1ab specific to SARS-CoV-2.
    J Virol Methods. 2023;320:114774.
    PubMed         Abstract available


  15. HARRIS E
    Human Infections With Swine Influenza Viruses Identified in US.
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.15451.

  16. ABBASI J
    A Genetic Explanation for Why Some People Had Asymptomatic COVID-19.
    JAMA. 2023 Aug 2. doi: 10.1001/jama.2023.14703.

    MMWR Morb Mortal Wkly Rep

  17. LINK-GELLES R, Ciesla AA, Rowley EAK, Klein NP, et al
    Effectiveness of Monovalent and Bivalent mRNA Vaccines in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters Among Children Aged 6 Months-5 Years - VISION Network, United States, July 2022-June 2023.
    MMWR Morb Mortal Wkly Rep. 2023;72:886-892.
    PubMed         Abstract available

    N Engl J Med

  18. RUSSELL FM, Curtis N, Carlin J
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:578-579.

  19. LADHANI SN, Andrews N, Ramsay ME
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.

    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2023;389:579.

  21. MURRAY EJ, Cowger TL, Hall KT
    Lifting Universal School Masking - Covid-19 Incidence among Students and Staff. Reply.
    N Engl J Med. 2023;389:580.

    PLoS Biol

  22. KRAFT TS, Seabright E, Alami S, Jenness SM, et al
    Metapopulation dynamics of SARS-CoV-2 transmission in a small-scale Amazonian society.
    PLoS Biol. 2023;21:e3002108.
    PubMed         Abstract available

    PLoS Comput Biol

  23. MARC A, Marlin R, Donati F, Prague M, et al
    Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
    PLoS Comput Biol. 2023;19:e1010721.
    PubMed         Abstract available

  24. YEDIDYA Y, Davis D, Drier Y
    SARS-CoV-2 infection perturbs enhancer mediated transcriptional regulation of key pathways.
    PLoS Comput Biol. 2023;19:e1011397.
    PubMed         Abstract available

  25. RAACH B, Bundgaard N, Haase MJ, Starruss J, et al
    Influence of cell type specific infectivity and tissue composition on SARS-CoV-2 infection dynamics within human airway epithelium.
    PLoS Comput Biol. 2023;19:e1011356.
    PubMed         Abstract available

  26. WOLFFRAM D, Abbott S, An der Heiden M, Funk S, et al
    Collaborative nowcasting of COVID-19 hospitalization incidences in Germany.
    PLoS Comput Biol. 2023;19:e1011394.
    PubMed         Abstract available

    PLoS One

  27. CACCIOTTOLO M, Li Y, Nice JB, LeClaire MJ, et al
    Nanograms of SARS-CoV-2 spike protein delivered by exosomes induce potent neutralization of both delta and omicron variants.
    PLoS One. 2023;18:e0290046.
    PubMed         Abstract available

  28. VELDKAMP R, Hek K, van den Hoek R, Schackmann L, et al
    Nivel Corona Cohort: A description of the cohort and methodology used for combining general practice electronic records with patient reported outcomes to study impact of a COVID-19 infection.
    PLoS One. 2023;18:e0288715.
    PubMed         Abstract available

  29. YARI A, Yousefi Khoshsabegheh H, Zarezadeh Y, Amraei M, et al
    Iranian primary healthcare system's response to the COVID-19 pandemic using the healthcare incident command system.
    PLoS One. 2023;18:e0290273.
    PubMed         Abstract available

  30. RIOS-GUTIERREZ A, Torres S, Arunachalam V
    An updated estimation approach for SEIR models with stochastic perturbations: Application to COVID-19 data in Bogota.
    PLoS One. 2023;18:e0285624.
    PubMed         Abstract available

  31. EBERLE RJ, Coronado MA, Gering I, Sommerhage S, et al
    Tau protein aggregation associated with SARS-CoV-2 main protease.
    PLoS One. 2023;18:e0288138.
    PubMed         Abstract available

  32. LYS AE, Huflejt-Lukasik M, Gambin M, Studzinska A, et al
    Predictors of pretraumatic stress during the COVID-19 pandemic in Poland.
    PLoS One. 2023;18:e0290151.
    PubMed         Abstract available

  33. ARONOFF-SPENCER E, Mazrouee S, Graham R, Handcock MS, et al
    Exposure notification system activity as a leading indicator for SARS-COV-2 caseload forecasting.
    PLoS One. 2023;18:e0287368.
    PubMed         Abstract available

  34. BOR A, Jorgensen F, Petersen MB
    The COVID-19 pandemic eroded system support but not social solidarity.
    PLoS One. 2023;18:e0288644.
    PubMed         Abstract available

  35. MOREIRA G, Qian H, Datta SPA, Bliznyuk N, et al
    A capacitive laser-induced graphene based aptasensor for SARS-CoV-2 detection in human saliva.
    PLoS One. 2023;18:e0290256.
    PubMed         Abstract available

  36. BESCHONER P, Jerg-Bretzke L, Erim Y, Geiser F, et al
    The prevalence of effort-reward imbalance and its associations with working conditions, psychosocial resources and burden among health care workers during the COVID-19 pandemic: Results of the egePan-Voice study.
    PLoS One. 2023;18:e0287509.
    PubMed         Abstract available

  37. SGORLON G, Roca TP, Passos-Silva AM, Queiroz JAS, et al
    The emergence of Omicron VOC and its rapid spread and persistence in the Western Amazon.
    PLoS One. 2023;18:e0285742.
    PubMed         Abstract available

  38. BRIOSCHI DOS SANTOS AP, Vicente CR, Cola JP, Tanaka LF, et al
    The impact of COVID-19 on maternal death and fetal death, a cohort study in Brazil.
    PLoS One. 2023;18:e0290343.
    PubMed         Abstract available

  39. SEKARAN K, Varghese RP, Doss C GP, Alsamman AM, et al
    Airway and Oral microbiome profiling of SARS-CoV-2 infected asthma and non-asthma cases revealing alterations-A pulmonary microbial investigation.
    PLoS One. 2023;18:e0289891.
    PubMed         Abstract available

  40. HOGG C, Boots S, Howorth D, Williams C, et al
    Test performance of lateral flow rapid antigen tests for COVID-19 in Welsh adult care home staff using routine surveillance data.
    PLoS One. 2023;18:e0290406.
    PubMed         Abstract available

  41. ANTONOVA L, Somayaji C, Cameron J, Sirski M, et al
    Comparison of socio-economic determinants of COVID-19 testing and positivity in Canada: A multi-provincial analysis.
    PLoS One. 2023;18:e0289292.
    PubMed         Abstract available

  42. FADLYANA E, Dhamayanti M, Tarigan R, Prodjosoewojo S, et al
    Immunogenicity and safety of Quadrivalent Influenza HA vaccine compared with Trivalent Influenza HA vaccine and evaluation of Quadrivalent Influenza HA vaccine batch-to-batch consistency in Indonesian children and adults.
    PLoS One. 2023;18:e0281566.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  43. RAO Z, Brunner E, Giszas B, Iyer-Bierhoff A, et al
    Glucocorticoids regulate lipid mediator networks by reciprocal modulation of 15-lipoxygenase isoforms affecting inflammation resolution.
    Proc Natl Acad Sci U S A. 2023;120:e2302070120.
    PubMed         Abstract available

  44. BOLTON MJ, Santos JJS, Arevalo CP, Griesman T, et al
    IgG3 subclass antibodies recognize antigenically drifted influenza viruses and SARS-CoV-2 variants through efficient bivalent binding.
    Proc Natl Acad Sci U S A. 2023;120:e2216521120.
    PubMed         Abstract available

  45. CIROVIC A, Cirovic A
    Could iron deficiency potentiate the appearance of complications in Influenza A virus infection?
    Proc Natl Acad Sci U S A. 2023;120:e2311262120.

  46. ALHAMMAD YM, Parthasarathy S, Ghimire R, Kerr CM, et al
    SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.
    Proc Natl Acad Sci U S A. 2023;120:e2302083120.
    PubMed         Abstract available

  47. ZHANG Q
    Complex Interplay between Population Immunity and Viral Dynamics.
    Proc Natl Acad Sci U S A. 2023;120:e2312198120.


  48. PALACHE A, Billingsley JK, MacLaren K, Morgan L, et al
    Lessons learned from the COVID-19 pandemic for improved influenza control.
    Vaccine. 2023 Aug 17:S0264-410X(23)00960-X. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  49. KENIGSBERG TA, Goddard K, Hanson KE, Lewis N, et al
    Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines.
    Vaccine. 2023 Aug 18:S0264-410X(23)00955-6. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available

  50. SU Y, Guo Z, Gu X, Sun S, et al
    Influenza vaccine effectiveness against influenza A during the delayed 2022/23 epidemic in Shihezi, China.
    Vaccine. 2023 Aug 19:S0264-410X(23)00971-4. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available


  51. XIAO Y, Wang L, Fang SS, Luo F, et al
    Direct blue 53, a biological dye, inhibits SARS-CoV-2 infection by blocking ACE2 and spike interaction in vitro and in vivo.
    Virology. 2023;586:105-114.
    PubMed         Abstract available

  52. RAMIREZ KA, Mond J, Papenburg J, Boivin G, et al
    In-vivo and human evidence for potential efficacy of therapeutic polyclonal RSV neutralizing antibodies for palivizumab-resistant RSV infections.
    Virology. 2023;586:115-121.
    PubMed         Abstract available

  53. BRIGGS K, Sweeney R, Blehert DS, Spackman E, et al
    SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro.
    Virology. 2023;586:122-129.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.